![](/img/cover-not-exists.png)
An FDA perspective on general pharmacology studies to determine activity and safety
Martin D. GreenVolume:
35
Year:
1995
Language:
english
Pages:
3
DOI:
10.1002/ddr.430350308
File:
PDF, 265 KB
english, 1995